SBT-TIP: Spontaneous Breathing Trial With T-piece or Inspiratory Pressure Augmentation
Study Details
Study Description
Brief Summary
Weaning is an important process to gradually separate mechanically ventilated patients from ventilators. A good weaning strategy aims to early identify mechanically ventilated patients who are ready for extubation but not to prematurely extubate them. Spontaneous breathing trial (SBT) is a test to assess the patient's ability to breathe spontaneously when extubated. Several methods have been used to conduct an SBT, including T-piece breathing, low-level pressure support ventilation (PSV) of 5-7 cm H2O, continuous positive airway pressure and automatic tube compensation (ATC).
The investigators hypothesized that an SBT with inspiratory pressure augmentation increases initial SBT success, reduces the length of invasive mechanical ventilation (iMV) support and does not increase reintubation risk as compared with T-piece, which result in a higher proportion of patients successfully liberated from iMV in the inspiratory pressure augmentation group. However, inspiratory pressure augmentation significantly reduces work of breathing on an SBT as compared with T-piece. Patients extubated following an SBT with inspiratory pressure augmentation may experience increased respiratory effort after extubation and this may increase the use of noninvasive ventilation after extubation. An SBT with inspiratory pressure augmentation increases iMV free days but not MV free days as compared with T-piece. Longer iMV free days may be associated with a lower mortality due to fewer iMV related complication.
This study is a pragmatic, cluster-randomized, multiple crossover, multicenter trial to compare SBTs with T-piece versus inspiratory pressure augmentation in weaning outcomes. Mechanically ventilated patients who meet the criteria for readiness to SBT will be included. The patients will use either T-piece or inspiratory pressure augmentation as SBT for weaning according to an ICU-based cluster randomization and crossover sequence.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Crossover sequence 1 Cluster-randomization crossover sequence 1: T-piece during odd-numbered months and inspiratory pressure augmentation during even-numbered months. |
Diagnostic Test: Spontaneous breathing trial (SBT) crossover sequence 1
SBTs with T-piece breathing for one hour during odd-numbered months and SBTs with inspiratory pressure augmentation for one hour during even-numbered months.
|
| Experimental: Crossover sequence 2 Cluster-randomization crossover sequence 2: T-piece during even-numbered months and inspiratory pressure augmentation during odd-numbered months. |
Diagnostic Test: Spontaneous breathing trial (SBT) crossover sequence 2
SBTs with inspiratory pressure augmentation for one hour during odd-numbered months and SBTs with T-piece breathing for one hour during even-numbered months.
|
Outcome Measures
Primary Outcome Measures
- Successful liberation from invasive mechanical ventilation [ICU discharge, up to 28 days after the initial SBT]
The primary study endpoint is to compare the effect of SBT with T-piece versus inspiratory pressure augmentation on the proportion of patients with successful liberation from invasive mechanical ventilation in the ICU among patients who have started an SBT. Successful liberation is defined as sustaining iMV free for at least five days after extubation.
Secondary Outcome Measures
- Successful liberation from invasive and noninvasive mechanical ventilation [ICU discharge, up to 28 days after the initial SBT]
Proportion of successful liberation from invasive and noninvasive mechanical ventilation in the ICU.
- Successful liberation from invasive mechanical ventilation [28 days]
Proportion of successful liberation from invasive mechanical ventilation on day 28 from intubation.
- Time to successful liberation from invasive mechanical ventilation [28 days]
Time to successful liberation from invasive mechanical ventilation using competing-risks analysis.
- Time to successful liberation from invasive and noninvasive mechanical ventilation [28 days]
Time to successful liberation from invasive and noninvasive mechanical ventilation using competing-risks analysis.
- Intubation free days [28 days]
The number of days that a patient is alive and free from intubation.
- Adjusted risk ratio of successful liberation from invasive mechanical ventilation [ICU discharge, up to 28 days after the initial SBT]
Adjusted risk ratio of successful liberation from invasive mechanical ventilation for T-piece versus inspiratory pressure augmentation group.
- Initial SBT success [During the ICU stay, up to 28 days]
Proportion of initial SBT success among patients who have started an SBT.
- Extubation failure [Five days from extubation]
Proportion of extubation failure among patients undergoing planned extubation.
- Proportion of planned extubation [ICU discharge, up to 28 days after the initial SBT]
Proportion of planned extubation in the ICU
- Use of noninvasive ventilation after extubation [Five days from extubation]
Proportion of use of noninvasive ventilation (>24 hours) after extubation.
- ICU mortality [ICU discharge, up to 28 days after the initial SBT]
Proportion of death in the ICU.
- 28-day mortality [28 days]
Probability of death in 28 days using kaplan-meier estimator.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Admitted to the adult intensive care unit (ICU)
-
Receiving invasive mechanical ventilation via an endotracheal tube
-
Ready to start an SBT* *The criteria of readiness to an SBT include FiO2 ≤ 0.4, PEEP ≤ 8 cmH2O, minute ventilation ≤ 0.15 L/min/predicted body weight, inspiratory pressure or driving pressure ≤ 14 cm H2O, stable cardiovascular status and no worsening of non-pulmonary organ function.
Exclusion Criteria:
-
Age < 20 years
-
Receiving mechanical ventilation via tracheostomy
-
Mechanical ventilation < 12 hours
-
Invasive ventilation started before the index hospitalization
-
On do-not-intubate order
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | National Taiwan University Hospital | Taipei | Please Select | Taiwan | 10002 |
| 2 | National Taiwan University Hospital Yunlin Branch | Yunlin | Taiwan | 63247 |
Sponsors and Collaborators
- National Taiwan University Hospital
Investigators
- Study Chair: Daniel Fu-Chang Tsai, MD, PhD, National Taiwan University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 201901036RINA